DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Ascend Partners
Ascend Partners
Private equity with venture activity · probableNew York, NYascendpartners.comSEC registered investment adviser
registered adviser; venture funds are 0% of 7 private funds
Importance
35
elevated
Active deployment
4
low
Emerging
0
low
Completeness
63
high
Freshness
99
high
Research priority
8
low
Identity and regulatory footprint
- Headquarters
- New York, NYadviserinfo.sec.gov
- Office address
- 300 PARK AVENUE, SUITE 2501, New York, NY, 10022-7405adviserinfo.sec.gov
- Business phone
- 646-689-2100adviserinfo.sec.gov
- Website
- HTTP://ASCENDPARTNERS.COM
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 30, 2024
- Private funds reported
- 7 (0 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $957Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $957Mthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 14
- business phone
- 646-689-2100adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, media
- Stages
- not stated or not yet read
- Geography
- new york
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
5 reported, 1 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Ascend Capital Partners Fund I-A, L.P. | Feeder or parallel · ADV: Private Equity Fund | 2021 adv first reported | Mature | $356M Mar 30, 2024 | 18 | $0 of $300M | Oct 19, 2020 |
| Ascend Capital Partners Fund I, L.P. | Fund · ADV: Private Equity Fund | 2021 adv first reported | Mature | $198M Mar 30, 2024 | 9 | $0 of $300M | Oct 19, 2020 |
| Ascend Capital Partners Co-Invest (blocker), L.P. | SPV or co-invest vehicle · ADV: Private Equity Fund | 2021 adv first reported | Mature | $103M Mar 30, 2024 | 6 | $0 of $300M | Oct 19, 2020 |
| Ascend Capital Partners Co-Invest, L.P. | SPV or co-invest vehicle · ADV: Private Equity Fund | 2021 adv first reported | Mature | $19.2M Mar 30, 2024 | 5 | $0 of $300M | Oct 19, 2020 |
| Ascend Capital Partners Fund I-Ff, L.P. | Fund · ADV: Private Equity Fund | 2020 form d first sale | Mature | $43.2M Mar 30, 2024 | 58 | $439M | Aug 6, 2021 |
| NEW Song Healthcare LP | Fund · ADV: Private Equity Fund | 2021 adv first reported | Wound down | $58.1M Mar 30, 2022 | 6 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
24 current, 0 departed
Bhaavika Guptha
AssociateAssociate
Michael Chu
AssociateAssociate
Michael Fong-Kutchins
AssociateAssociate
Alok Sanghvi
Board or advisorySenior Advisor
Lindsay West
Investor relationsSenior Associate, Investor Relations & ESG
Shannon Cranshaw
Investor relationsVice President of Investor Relations
IN Seon Hwang
Managing partnerManaging Partner
Inseon Hwang
Managing partnerManaging Partner Of The Filing Adviser · since Apr 1, 2020
Richard Park
Managing partnerManaging Partner
Richard Park
Managing partnerManaging Partner Of The Filing Adviser · since Apr 1, 2020
Bonnie Lance
OtherHead of Fund Administration
Bonnie Marie Lance
OtherHead Of Fund Administration · since Aug 1, 2020
Diana Prilepsky
Platform and operationsExecutive Assistant
Duwain Alester Robinson
Platform and operationsChief Compliance Officer · since Dec 1, 2020
Duwain Robinson
Platform and operationsPartner, CFO & CCO
Jennifatu Crowther
Platform and operationsAssistant Vice President - Finance, Tax, & Compliance
Kenzie Finizio
Platform and operationsAdministration & Operations Associate
Mark Tolmach
Platform and operationsAssistant Vice President – Finance
Gabriel Oriente
PrincipalPrincipal
Joshua Zenilman
PrincipalPrincipal
Adam Taitz
Vice presidentVice President
Arielle Eacho
Vice presidentVice President
Hailey Salito
Vice presidentVice President
Hayley Kim
Vice presidentVice President
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Go to | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
2 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- Mar 31, 2023NEW Song Healthcare LP no longer reported on Form ADV by Ascend PartnersFund no longer reportedFundsInferenceNEW Song Healthcare LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Ascend Capital Partners Fund I, L.P. first reported on Form ADV by Ascend Partners (Private Equity Fund), GAV $68,430,223Fund first reported on Form ADVFundsFactAscend Capital Partners Fund I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Ascend Capital Partners Co-Invest, L.P. first reported on Form ADV by Ascend Partners (Private Equity Fund), GAV $13,650,112Fund first reported on Form ADVFundsFactAscend Capital Partners Co-Invest, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Ascend Capital Partners Co-Invest (blocker), L.P. first reported on Form ADV by Ascend Partners (Private Equity Fund), GAV $76,610,812Fund first reported on Form ADVFundsFactAscend Capital Partners Co-Invest (blocker), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021NEW Song Healthcare LP first reported on Form ADV by Ascend Partners (Private Equity Fund), GAV $50,916,255Fund first reported on Form ADVFundsFactNEW Song Healthcare LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Ascend Capital Partners Fund I-A, L.P. first reported on Form ADV by Ascend Partners (Private Equity Fund), GAV $10,027,997Fund first reported on Form ADVFundsFactAscend Capital Partners Fund I-A, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 1, 2020Duwain Alester Robinson joined Schedule A of Ascend Partners as Chief Compliance Officer
- Aug 19, 2020Ascend Capital Partners Fund I-Ff, L.P. first reported on Form ADV by Ascend Partners (Private Equity Fund), GAV $5,650,000Fund first reported on Form ADVFundsFactAscend Capital Partners Fund I-Ff, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 19, 2020Ascend Partners first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 0% of 7 private funds
Evidence
25 observations from 2 sources